Aura Biosciences (AURA) Earnings Date & Reports

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AURA is expected to report earnings to fall 6.76% to -51 cents per share on August 07

Aura Biosciences AURA Stock Earnings Reports

Q2'25

Est.

$-0.51

Q1'25

Missed

by $0.07

Q4'24

Missed

by $0.08

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.04

The last earnings report on May 15 showed earnings per share of -55 cents, missing the estimate of -47 cents. With 217.37K shares outstanding, the current market capitalization sits at 367.69M.

View a ticker or compare two or three

Compare

AURA